1998

Indegene founded

2000

Introduced medical education services to Indian pharmaceutical companies

Launched Indegene Mobile Health System (IMHS) for medical doctors to easily access licensed medical content via PalmPilots

2001

Recognized by Lancet as the most credible source of specialized medical information in India

Selected by WHO as their partner to implement a nationwide healthcare information project

2003

Made a successful entry into sales training through launch of e-learning platform in diabetes across S.E. Asia

2004

Incorporated 100% subsidiaries in the United States and Singapore

2005

Nadathur Investments invested in Indegene

Set up operations in the United States

Acquired Medsn, a pharma sales training company in the United States

2006

Ramped up operations in Southeast Asia

Acquired MedCases, a medical e-learning solutions company in the United States

2007

Kicked off operations in Europe

Received ISO 9001 and ISO 27001 certifications

Launched Medical Affairs services

2010

Built China Operation Center at Shanghai and Dalian

2011

Launched Analytics services

2012

Introduced Regulatory Affairs and Safety services

Acquired Aptilon, a customer engagement technology company

2013

Acquired Total Therapeutic Management (TTM), a healthcare quality improvement and clinician engagement company

2015

Acquired SmartCare, a population health analytics platform

2016

Acquired Skura Technologies to expand omnichannel and commercial solutions

Acquired Encima to strengthen omnichannel analytics capabilities

Introduced next-generation, fully integrated product commercialization solutions

Acquired Wincere to strengthen footprint in R&D and Medical offerings for life sciences

2017

Introduced Clinical services

2019

Acquired DT Associates, a digital transformation and customer experience consulting firm in the UK

Launched Indegene Digital Summit, a flagship thought leadership event

2020

Set up operations in Japan

2021

The Carlyle Group and Brighton Park Capital invested US$ 200 million in Indegene

Indegene refreshed its brand to align with its purpose - To enable healthcare organizations be future-ready

Strengthened pricing, reimbursement and market access capabilities with MME acquisition

2022

Acquired CultHealth, a full-service healthcare marketing agency to elevate brand experience

2023

Opened strategic center in Germany

2024

Set up a new global delivery center in Hyderabad

Acquired Trilogy Writing & Consulting GmbH, a medical writing consultancy

Indegene listed on NSE and BSE

2025

Acquired MJL Life Sciences to expand healthcare communications in the UK

Launched a new entity in Spain

Opened a new center in London